SCHEMBL6256607

SCHEMBL6256607

COc1ccc(CC(O)CN2C[CH]N(CCc3ccc(Cl)cc3Cl)CC2)cc1

nearest known ligand 0.47

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 1/20 0.47
MEN1 O00255 1/20 0.42
KMT2A Q03164 1/20 0.42
IDO1 P14902 1/20 0.42
MAPT P10636 1/20 0.40
MAOA P21397 1/20 0.39
MAOB P27338 1/20 0.39
LMNA P02545 2/20 0.38
MAPK1 P28482 1/20 0.38
HTT P42858 1/20 0.38
F10 P00742 1/20 0.38
HTR1A P08908 1/20 0.38
HTR7 P34969 1/20 0.38
CACNA1G O43497 1/20 0.38
KCNH2 Q12809 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.37
SIGMAR1 Q99720 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5223079 0.90 CYP2D6 (0.48) CYP2D6MEN1KMT2AIDO1MAPT
SCHEMBL5225645 0.84 CYP1A2 (0.48) CYP2D6MEN1KMT2AMAPTLMNA
SCHEMBL6261178 0.83 MEN1 (0.47) CYP2D6MEN1KMT2AIDO1MAPT
SCHEMBL6188797 0.83 CYP2D6 (0.55) CYP2D6MEN1KMT2AMAPTLMNA
SCHEMBL5223033 0.80 MEN1 (0.47) CYP2D6MEN1KMT2AMAPTLMNA
SCHEMBL5226751 0.79 CYP2D6 (0.54) CYP2D6MAPTLMNAMAPK1HTT
SCHEMBL4511466 0.77 MEN1 (0.54) CYP2D6MEN1KMT2ALMNAMAPK1
SCHEMBL5224759 0.75 CYP1A2 (0.48) CYP2D6MEN1KMT2AMAPTLMNA
SCHEMBL4510340 0.75 MEN1 (0.50) CYP2D6MEN1KMT2ALMNAHTT
SCHEMBL5228642 0.72 CYP1A2 (0.47)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1578737-A1 SUBSTITUTED HETEROCYCLIC COMPOUNDS CV THERAPEUTICS, INC. (US) 2005-09-28 EP disclosed
WO-2004063180-A1 SUBSTITUTED HETEROCYCLIC COMPOUNDS CV THERAPEUTICS, INC. (US) 2004-07-29 WO disclosed